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DETERMINING THE ROLE OF MYELIN IN MAINTAINING AXON INITIAL 
SEGMENT STABILITY 
 
By Anne Marie Josephson, B.S. 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2013. 
 
Major Director:  Jeffrey L. Dupree, Ph.D. 
Associate Professor of Anatomy and Neurobiology 
 
 
 
 
Axonal pathology is a major contributor to impaired motor, sensory and cognitive 
dysfunction associated with multiple sclerosis particularly with the progressive forms of 
the disease. However, the early pathologic events responsible for axonal deterioration 
remain unclear. It is well recognized that maintaining proper axonal function is intimately 
related to proper establishment and maintenance of axonal domains such as the node of 
Ranvier and the axon initial segment (AIS). Numerous laboratories, including ours, have 
investigated the mechanisms that regulate node of Ranvier formation and maintenance. 
These studies have shown that node of Ranvier formation and maintenance require myelin 
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contact. Interestingly, many of the same proteins that cluster at the node of Ranvier also 
cluster in the AIS; however, the mechanisms responsible for AIS clustering appear to be 
unique to the AIS as myelin contact is not required and the mechanisms appear to be 
intrinsic to the neuron. Determining how the AIS is developmentally generated is vital to a 
complete understanding of the AIS function. However, more in line with understanding the 
pathobiology of MS, our laboratory is interested in identifying the mechanisms responsible 
for the maintenance and restoration of AIS integrity and function. To achieve this goal, we 
have exploited the cuprizone toxicity model. This model results in a consistent course of 
demyelination followed by remyelination of layer V of the cerebral cortex. Using a 
combination of immunocytochemistry and confocal microscopy, we have analyzed AIS 
integrity as evidenced by the clustering of ankyrinG, a prominent initial segment protein. 
Our findings indicate that the number of AIS is not decreased following myelin loss. In 
addition, AIS length and surface area are not changed following demyelination. These 
findings are important as they suggest that myelin is not required for the maintenance of 
initial segment organization.  
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Introduction 
 
 
 
The integrity of the myelin sheath is necessary to maintain normal central nervous system 
(CNS) function.  The maintenance of the CNS myelin sheath is dependent on proper 
functioning of oligodendrocytes and the viability of the axons they ensheathe (Quarles et 
al., 2006). Myelin deficiencies may result from a variety of causes, including 
autoimmunity, viral infections, genetic defects, toxic agents, malnutrition and trauma, 
which can affect myelin, oligodendrocytes or myelinated neurons (Quarles et al., 2006). A 
prominent myelin deficient disease affecting more than two million people worldwide is 
multiple sclerosis (MS) (Dutta and Trapp, 2011). While it is known that axon pathology is 
a major contributor to impaired motor, sensory and cognitive dysfunction associated with 
MS (Dutta and Trapp, 2011), the early pathological events responsible for axonal 
deterioration remain unclear. There are ongoing studies investigating whether axonal 
pathology associated with MS is a primary consequence of the disease or whether it is a 
secondary consequence of demyelination. Here, I will investigate the relationship between 
demyelination and axonal pathology as a secondary event specifically focusing on the AIS. 
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Myelin 
 
The myelin sheath is an extended plasma membrane that wraps around the neuronal axon 
and functions in facilitating the conduction of nerve impulses by acting as an insulator. 
Myelin in the CNS originates from oligodendrocytes (Raine, 1984). An oligodendrocyte 
extends multiple membranous processes and each process contacts and wraps around a 
segment of an axon forming a multilayered sheath. The short portions of the axon that are 
not covered by myelin are called the nodes of Ranvier. The lateral edges of the myelin 
sheath terminate at the node forming paranodal loops, which participate in the formation of 
paranodal junctional complexes (Quarles et al., 2006). A structural component of these 
complexes is transverse bands, which anchor the myelin sheath to the plasma membrane of 
the axon, or axolemma, (Dupree et al., 1998) and establish and maintain axonal protein 
domains (Dupree et al., 1999). The segments of myelinated axons between the nodes are 
known as the internodes (Quarles et al., 2006). 
 
CNS myelin is composed of approximately 30% proteins and 70% lipids. Of the protein 
component, 60-80% is composed of the myelin proteins, proteolipid protein (PLP) and 
myelin basic protein (MBP), with the remaining 20-40% being comprised of other minor 
proteins discussed below (Quarles et al., 2006). PLP makes up greater than 50% of the 
protein in CNS myelin (Hudson, 2004). The genes of PLP and its alternatively spliced 
isoform, DM20, are expressed early in development. DM20 mRNA is known to appear 
even before myelination is initiated. Consistent with a possible role in oligodendrocyte 
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migration or differentiation (Hudson, 2004), PLP and DM20 are also known to play a role 
in the stabilization of the intraperiod line (Boison and Stoffel, 1994; Duncan et al., 1987), 
defined as the apposition of  the extracellular surfaces of adjacent layers of the myelin 
sheath (Fredrik et al., 2011). Although PLP and DM20 serve an important structural and 
stabilizing role in myelin, the formation of compact, multilamellar myelin is not dependent 
on them (Coetzee et al., 1999). A PLP/DM20 knockout mouse initially appeared relatively 
normal with respect to myelin formation, life span and motor performance (Hudson, 2004). 
However, the PLP-null mutant is extra sensitive to osmotic shock during fixation, 
suggesting that PLP may enhance the stability of myelin (Hudson, 2004). In older 
PLP/DM20 knockout mice there is significant axonal damage. This suggests that while 
myelin can form in the absence of PLP/DM20, it is required for the maintenance of axonal 
structure and function (Hudson, 2004). Interestingly, despite the similarity of PLP and 
DM20, DM20 cannot replace PLP since the same axonal degeneration was observed in 
mice only expressing DM20 (Stecca et al., 2000).  
 
MBP comprises 30% of CNS myelin proteins (Liu, 2006). There are four classic isoforms 
of MBP, whose ratios change with development (Norton and Cammer, 1984). MBP is 
believed to be the principle protein stabilizing the major dense line of CNS myelin 
(Quarles et al., 2006). Seven exons of the MBP gene are deleted in the shiverer mouse 
causing a lack of MBP and major dense lines (Gumpel et al., 1983). In the shiverer mouse 
myelin sheaths form, but are severely hypomyelinated and uncompacted suggesting that 
MBP is necessary for myelin compaction (Gout et al., 1988).  
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Other proteins present in myelin include 2’:3’-cyclic nucleotide 3’-phosphodiesterase 
(CNP), myelin-associated glycoprotein (MAG) and myelin-oligodendrocyte protein 
(MOG). CNP is enriched in CNS myelin and oligodendrocytes and is associated with 
regions of noncompact myelin, such as the oligodendroglial processes and paranodal loops 
(Quarles et al., 2006; Kursula, 2008). MAG is present in minor concentrations at the 
periaxonal glial membranes of myelin (Sternberger et al., 1979; Quarles et al., 2006). Not 
only does MAG’s proximity to the axon and its inclusion in the Ig superfamily suggest that 
it functions in adhesion and signaling between myelin-forming cells and the axolemma 
(Quarles et al., 1992), but it is also known to bind axonal gangliosides GD1a and GT1b 
(Schnaar, 2010). It is known that MAG-null mice myelinate relatively normally; therefore, 
MAG is not essential for myelin formation (Quarles et al., 2006). Unlike MAG, MOG is 
localized on the outermost surface of myelin sheaths and oligodendrocytes. Similar to 
MAG, its location suggests that it may function in signal transduction. MOG-null mice 
exhibit a normal phenotype, leaving its physiological function unclear (Quarles et al., 
2006). 
 
Axonal Domains  
 
In addition to providing insulation to the axon, the myelin sheath also serves to divide the 
axon into molecularly and functionally distinct domains. These distinct domains include 
the internode, the juxtaparanode, the paranode, the axon initial segment (AIS) and the node 
of Ranvier (Peles and Salzar, 2000; Salzar, 1997; Arroyo and Scherer, 2000).    
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Figure 1. Domains of myelinated axons. An illustration of a longitudinal section through 
the nodal region of a myelinated axon shows the organization and composition of axon 
domains in relation to the myelin sheath.  Beneath the compact myelin (CM) is the 
internode, which is adjacent to the juxtaparanode. K+ channels and caspr2 are concentrated 
at juxtaparanodal regions. The CM sheath opens into a series of perinodal cytoplasmic 
loops (PNL) at the paranode. Paranodal proteins include caspr, contactin and neurofascin-
155. The node of Ranvier lacks myelin and contains Na+ channels, ankyrinG, NrCAM and 
neurofascin-186. (Adapted from Peles and Salzar, 2000). 
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The internode is the region of the axon covered by the compact myelin sheath. It is the 
longest segment of the myelinated axon (Trapp and Kidd 2004). There are no known 
proteins specifically enriched in the CNS internode (Peles and Salzar, 2000). Additionally, 
the molecules that maintain myelin-axon adhesion remain unknown. However, dual 
elimination of MAG and myelin galactolipids result in internodal myelin deterioration 
suggesting possible roles in adhesion (Marcus et al., 2002).   
 
Juxtaparanodes comprise the region of axon covered by compact myelin (Peles and Salzar, 
2000). The juxtaparanode may be considered a specialized portion of the internode 
containing the K+ channels Kv1.1, Kv1.2 and their Kvβ2 subunit. These channels are 
important in maintaining the internodal resting potential by quickly repolarizing the axon 
following an action potential (Wang et al., 1993; Rasband et al., 1998; Vabnick et al., 
1999). Associating with these K+ channels is the protein, caspr2 (contactin-associated 
protein 2) (Poliak et al., 1999), forming a complex with transient axonal glycoprotein-1 
(TAG-1) (Traka et al., 2003). This interaction with TAG-1 provides anchorage between the 
myelin sheath and axon (Wang et al., 1993).  
 
Compact myelin lamellae open into a series of loops that spiral around and closely appose 
the axon on either side of the node of Ranvier at paranodal junctions. Paranodes are located 
adjacent to juxtaparanode and are important in anchoring the myelin loops to the axon 
(Rosenbluth, 1995). The axo-glial junctions found at the paranode include two axonal 
membrane proteins known as contactin and caspr (contactin-associated protein) (Peles et 
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al., 1997). Caspr and contactin form a cis complex (Tait et al., 2000) that binds to the 
oligodendrocyte protein neurofascin-155 (NF-155) (Davis et al., 1996). Together these 
proteins form an axo-glial complex with caspr serving as the transmembrane scaffold that 
stabilizes the complex with cytoskeletal anchors (Gollan et al., 2002). 
 
The AIS is the unmyelinated region of the axon just distal to the cell body, which is 
responsible for the initiation, modulation and propagation of action potentials (Buffington 
and Rasband, 2011).  In the AIS there is an enrichment of voltage-gated Na+ channels, 
most popularly Nav 1.6 (Caldwell, et al., 2000), but also Nav 1.2 and Nav 1.1 (Buffington 
and Rasband, 2011). These channels are responsible for inward current flow and control 
action potential initiation and propagation (Peles and Salzar, 2000; Buffington and 
Rasband, 2011). Binding to and anchoring voltage-gated Na+ channels is the cytoskeletal 
scaffolding protein, ankyrinG (ankG) (Buffington and Rasband, 2011). AnkG colocalizes 
with the actin-binding protein, βIV spectrin, and anchors the neural cell adhesion molecule 
(NrCAM) and neurofascin186 (NF-186) to the axon (Kordeli et al., 1990; Berghs et al., 
2000). These axo-glial interactions are essential for proper functioning of the axon.  
 
Similar to the AIS, another area of the axon lacking myelin is the node of Ranvier. The 
node is important in propagating the action potential initiated at the AIS. Interestingly, 
both the AIS and node have a similar protein composition. At the node there is also an 
enrichment of voltage-gated Na+ channels (Peles and Salzar, 2000; Buffington and 
Rasband, 2011), which are anchored by ankG (Buffington and Rasband, 2011). In the node 
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Figure 2. Axon Initial Segment and Paranodal Proteins. Ion channels, cell adhesion molecules, 
neurotransmitter receptors and cytoskeletal proteins are enriched at the AIS. Nav 1.2 channels are clustered at 
more proximal regions of the AIS, while Nav 1.6 channels are found at distal regions. Similarly GABAA 
receptors are only found at distal AIS. At the paranode caspr and contactin are bound in cis. They form a 
complex with the glial protein, neurofascin-155. 
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ankG colocalizes with βIV spectrin and interacts with NrCAM and NF-186, as well (Peles 
and Salzar, 2000; Buffington and Rasband, 2011).  
 
Formation of Nodes of Ranvier 
 
Studies have shown the importance of myelin for the formation of nodal clustering. Using 
lysolecithin to induce demyelination, Dugandžija-Novaković et al. (1995) first reported 
that nodal Na+ channel clustering was dependent on myelination. In this study, the authors 
reported that Na+ channel clustering only occurred in the areas of remyelination.  
Following the injection of the demyelinating agent, Na+ channel clustering was only seen 
at heminodes, which marked the transition from myelinated to demyelinated regions at the 
edge of the injected zone, and at widely spaced sites that were thought to be former nodes. 
As the myelinating Schwann cells proliferated and repopulated the demyelinated region, 
myelin forming processes adhered to axonal internodes and as the myelinating processes 
advanced along the axon, Na+ channel clusters appeared at the borders of these processes. 
As the Schwann cell processes continued to advance along the unmyelinated axon, the 
clusters remained at the edges and moved with the process as it elongated during 
remyelination. As the remyelinating process continued, the Na+ channel cluster at the edge 
of one process approached the cluster at the edge of an adjacent process eventually forming 
a new node.  
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Vabnick and Shrager (1998) further looked into myelin’s role in Na+ channel clustering 
during development. They observed that it is only after the expression of myelin-associated 
glycoprotein (MAG), a myelin-forming cell protein that is expressed after the cell has an 
overlapping ensheathement and is committed to myelination (Martini and Schachner, 
1986), that the frequency of occurrence of Na+ channel clusters rises sharply. Together, 
with the previous work of Dugandžija-Novaković et al. (1995), these findings suggests that 
not only does myelin mediate formation of Na+ channel clusters in the PNS, but there must 
also be close axon-glial contact for the initiation of nodal clusters (Vabnick and Shrager, 
1998). 
 
Using mice that lack galactose-ceramide galactosyltransferase (CGT), an enzyme needed 
for the production of the myelin components, galactocerebroside (GalC) and sulfatide 
(Morell and Radin, 1969), Dupree et al. (1999) showed the importance of axo-glial 
interactions in the molecular organization of the nodal region of the CNS. In the spinal 
cords of CGT knock outs, nodal and paranodal abnormalities were observed including 
altered node length, terminal loops that frequently face away from the axon and a complete 
absence of transverse bands, which are prominent components of the paranodal septate-
junctions (Dupree et al., 1998 and Popko, 2000). This severe alteration in axo-glial 
interactions resulted in abnormal ion channeling clustering with elongated nodal Na+ 
channel clusters and failure of K+ channel clustering at the juxtaparanode (Dupree et al., 
1999).  
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Although these early studies demonstrated the importance of the myelin sheath and its 
proper adhesion to the axon in the regulation of the ion channel clustering, these studies 
did not identify the molecules that mediate domain formation.  More recently, Peles and 
colleagues reported that initial step in Na+ channel clustering in the PNS involves the 
Schwann cell protein gliomedin (Eshed et al., 2005). As shown by Bhat (Thaxton and 
Bhat, 2009) and others (Labasque et al., 2011), gliomedin binds the extracellular domain of 
the neuronal nodal protein, neurofascin186 (NF-186), which initiates the recruitment of 
other nodal proteins (Lambert et al., 1997; Eshed et al., 2005; Schafer et al., 2006; 
Feinberg et al., 2010). After NF-186 is localized to the node, it recruits ankG to the node 
through its FIGQY binding motif (Dzhashiashvili et al., 2007). Nav channels then bind to 
ankG (Rasband, 2008). AnkG also interacts with the neuronal cytoskeleton through its 
interaction with βIV spectrin (Berghs et al., 2000), an actin binding protein that serves to 
link nodal proteins to the neuronal cytoskeleton (Buffington and Rasband, 2011).  
 
The formation of CNS nodes is not as well understood. One hypothesis suggests that a 
possible candidate for a CNS equivalent to gliomedin is the extracellular matrix (ECM) 
protein, brevican, which is known to localize to the node (Bekku et al, 2009). However, 
ablation of brevican in mice revealed no major defects in nodal organization (Brakebush et 
al., 2002), but it may be possible that other proteins function together with brevican to 
organize the node and compensate in the brevican knockout mice (Buttermore et al., 2013). 
Therefore, the protein that initiates CNS nodal ion channel clustering remains unclear. 
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Although conflicting, other work has proposed that oligodendrocytes have the ability to 
induce Na+ channel clustering through secretion of soluble factors independent of myelin 
contact (Kaplan et al., 1997). However, further examination revealed that in the 
oligodendrocyte conditioned medium only Nav 1.2 channels, the immature Nav channel 
isoform, clustered at the node. Subsequent work by Kaplan et al. (2001) revealed that 
myelination is required for the clustering of Nav 1.6 channels, the mature nodal isoform, at 
the nodes. Although the role of a soluble factor has not been disproved, at least for the 
clustering of the immature form of Na+ channels, overwhelming evidence indicates that 
myelin sheath formation is required for CNS nodal clustering. Using a mouse that exhibits 
severe hypomyelination of the CNS, Rasband et al. (1999) demonstrated that CNS nodal 
clustering required myelin-axon contact. Moreover, nodal clustering of ankyrinG was also 
shown to be dependent on axo-glial contact.  
 
Formation of AIS 
 
Unlike the node, formation of the AIS does not require myelin and occurs intrinsically 
though the localization of ankG (Bennett and Baines, 2001). Although the signals 
responsible for ankG localization to the AIS are still unknown, it is known that ankG is a 
cytoskeletal scaffolding protein that functions to stabilize proteins by linking them to the 
actin-spectrin cytoskeleton (Bennett and Lambert, 1999). More specifically, following 
ankG localization to the AIS it then recruits βIV spectrin (Yang et al., 2007). It is through 
ankG interaction with βIV spectrin that it associates with the actin cytoskeletal network 
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(Buffington and Rasband, 2011). Recent work has shown that Nav 1.6 channels’ ankG-
binding domain is required for their localization at the AIS (Gasser et al., 2012). The 
importance of ankG in AIS formation is shown in studies using ankG knockouts and 
knockdowns since genetic ablation of ankG results in failure of NF-186 and ion channel 
clustering at the AIS (Zhou et al, 1998; Hedstrom et al., 2007).  
 
While ankG is necessary for initial AIS organization, recent work has shown that NF-186 
is needed for AIS maturation (Buttermore et al., 2012). A critical step in the maturation 
process of the AIS is the switch in the expression of Nav 1.2 channels to the expression of 
Nav 1.6.  (Boiko et al., 2003; Van Wart and Matthews, 2006). A similar switch is 
expression also occurs at the node (Boiko et al., 2001); however, at the node a complete 
switch occurs. In contrast, at the AIS, Nav 1.2 remains but is restricted to the proximal 
portion of the AIS while Nav 1.6 clusters at the distal region of the AIS. (Hu et al., 2009).  
In the absence of NF-186, mature Nav 1.6 channels are not enriched at the AIS and the Nav 
1.2 channels persist (Buttermore et al., 2012). This suggests that initial clustering 
mechanisms are distinct from those that regulate maturation and perhaps maintenance.  
 
Maintenance of Nodes of Ranvier  
 
In addition to playing a critical role in initiating Na+ channel clustering, the myelin sheath 
also is essential for maintaining the clustering of these ion channels. The previously 
mentioned work performed by Dugandžija-Novaković et al. (1995) also highlights the 
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importance of myelin in the maintenance of Na+ channel clusters. Following lysolecithin 
injection, myelin is completely void from the focal area after one week coinciding with the 
loss of Na+ channel clusters (Dugandžija-Novaković et al. 1995). For example, using a 
conditional knockout approach, Pillai et al. (2009) generated a mouse that lost expression 
of NF-155, the glial-specific neurofascin expressed at the paranode, after initial Na+ 
channel clustering occurred.  These mice exhibited disassembly and distal unraveling of 
axo-glial junctions from the juxtaparanode towards the node. Although the node initially 
remained intact, with extended time NF-186, Nav channels and ankG diffused out 
indicating that the long-term integrity of the node relies on myelin-axon contact (Thaxton 
and Bhat, 2009).  
 
Studies have also examined the role of nodal proteins in the organization and stabilization 
of CNS nodes.  Deficiencies in βIV spectrin resulted in altered axonal shape (Yang et al., 
2004) and decreased levels of ankG and Nav channels at nodes suggesting its role in node 
stabilization (Komada and Soriano, 2002; Lacas-Gervias et al., 2004). Mice that lacked 
both NF-186 and NF-155 exhibited a complete disorganization of both the paranode and 
node (Sherman et al., 2005) while absence of only NF-186 resulted in the invasion of 
paranodal proteins into the nodal gap (Thaxton et al., 2011).  
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Maintenance of AIS 
 
AnkG is not only essential for AIS assembly (Hedstrom et al., 2007), but is also required 
for AIS maintenance (Hedstrom et al., 2008). Using gene silencing mechanisms, it has 
been shown that loss of ankG from the AIS results in a disassembling of AIS protein 
clusters (Hedstrom et al., 2008). In this study neurons lacking ankG also had a decrease in 
Nav channels, βIV spectrin, NF-186 and NrCAM, a neuronal cell adhesion molecule 
(Thaxton and Bhat 2009). Therefore ankG is not only necessary for the initial recruitment 
of these protein clusters to the AIS, but also their long-term stability (Hedstrom et al., 
2008). These artificial conditions have shown the importance of ankG in AIS maintenance, 
but no study has investigated myelin’s role in maintaining the AIS. This is an important 
question since the loss of myelin is known to contribute to axonal pathology in disease, 
such as multiple sclerosis.   
 
Multiple Sclerosis  
 
Multiple sclerosis (MS) is the leading cause of non-traumatic neurological disability in 
young adults in the United States and Europe (Dutta and Trapp, 2011). MS is a disease 
affecting the CNS that involves both inflammation and widespread myelin loss. MS is 
diagnosed by the presence of multifocal inflammatory demyelinated plaques within the 
CNS. In addition to demyelination and multifocal inflammation, other pathologies 
associated with MS include the breakdown of the blood-brain barrier (BBB) and reactive 
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gliosis. However, the primary pathology of MS is characterized by an immune-mediated 
destruction of myelin and oligodendrocytes in the CNS, but studies have shown that 
progressive axonal loss is the major cause of irreversible neurological disability in MS 
(Stadelmann et al., 2008; Trapp and Nave, 2008).  
 
MS Inflammation 
 
While the CNS has few lymphocytes present in the absence of infection, a small 
population of lymphocytes provides surveillance for infection or injury and is part of a 
healthy immune system (Hickey et al, 1991; Wekerle et al., 1987). Moreover, these 
lymphocytes may also provide important inflammatory signals needed for wound healing, 
angiogenesis and neuroprotection (Hauser and Oksenberg, 2006). However, the transition 
from healthy to pathological autoimmunity can occur. T cells activated in the periphery 
cross the BBB and enter the CNS (Hauser and Oksenberg, 2006; Hickey et al., 1991; 
Wekerle et al., 1987). Activation of autoimmune responses against myelin components in 
the CNS is hypothesized to occur through a variety of mechanisms such as molecular 
mimicry, bystander activation and epitope spreading (Vanderlugt and Miller, 2002; von 
Herrath et al., 2003). Once activated, myelin-specific T cells can cross the BBB where they 
proliferate and secrete pro-inflammatory cytokines, such as TNF- α (Peterson and 
Fujinami, 2007). These cytokines stimulate microglia, macrophages and astrocytes, and 
recruit B cells, which ultimately results in damage to myelin, oligodendrocytes and axons 
(Zamvil and Steinman, 2003). 
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MS Demyelination 
 
Demyelination associated with “MS lesions,” the breakdown of the BBB, infiltration of 
lymphocytes, demyelination and oligodendrocyte death, occurs throughout the CNS (Dutta 
and Trapp, 2011). While MS was initially regarded as a white matter disease, with an 
autoimmune response against myelin, the involvement of grey matter is becoming more 
evident. As is the case in white matter, axons in the grey matter are myelinated, and 
demyelination of axons in grey cortical matter regions has been reported as a prominent 
feature on post-mortem examination of patients with MS (Bo et al., 2003).   
 
Axonal Pathology Associated with MS 
 
Axonal loss could be a result of nonspecific damage caused by inflammation (Trapp et al, 
1998; Dutta and Trapp, 2010). During the inflammatory process activated immune and 
glial cells release many substances including proteolytic enzymes, cytokines, oxidative 
products and free radicals that can damage axons (Hohlfeld, 1997). Inflammation also 
affects energy metabolism, ATP synthesis and mitochondrial DNA and impairs the 
mitochondrial enzyme complexes (Lu et al., 2000; Dutta et al., 2006) While the 
mechanisms of axon loss are unknown, there is a strong correlation between inflammation 
and axon transection suggesting that immune-mediated mechanisms may contribute to 
axonal pathology in MS (Dutta and Trapp, 2010). However, studies have shown that axon 
injury and loss are also evident in chronically demyelinated lesions where little or no 
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active inflammation was observed. This would suggest that myelin plays an important role 
in maintaining axon integrity. More specifically, myelin is known to be important in the 
maintenance of axonal domains ((Dupree et al., 1999; Dupree et al., 2004; Marcus et al., 
2006; Pomicter et al., 2010), which is essential for proper axonal function. 
 
Myelin is Required for the Maintenance of Axonal Domains 
 
It is recognized that maintaining proper axonal function is intimately related to proper 
establishment and maintenance of axonal domains such as the node of Ranvier and the AIS 
(Bhat et al, 2001; Buttermore et al., 2013). Previous studies in our lab have determined that 
myelin contact is required for node of Ranvier formation and maintenance (Dupree et al., 
1999; Dupree et al., 2004; Marcus et al., 2006; Pomicter et al., 2010). While the node of 
Ranvier and AIS cluster many of the same proteins (Buffington and Rasband, 2011), the 
mechanisms responsible for initial AIS protein clustering appear to be unique since myelin 
contact is not required (Zonta et al., 2011). Although studies have investigated the 
mechanisms that initiate protein clustering at the AIS (Hedstrom et al., 2007), there are no 
studies that have addressed the maintenance of these axonal domains. Here, we address 
this void in our understanding by testing the hypothesis that myelin is required to maintain 
AIS protein clusters.  
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Models of Demyelination 
 
To investigate the role that myelin plays in the maintenance of protein clusters within the 
AIS, we needed to choose the most appropriate model of CNS demyelination and 
remyelination. The ideal model would generate a highly reproducible lesion of the grey 
matter, specifically target oligodendrocytes, and exhibit minimal general toxicity and 
inflammatory responses. Within the myelin literature, several models have been 
characterized including Theiler’s Murine Encephalomyelitis Virus (TMEV), lysolecithin 
and cuprizone. TMEV is single stranded RNA virus that belongs to the family 
Picornaviridae (Roos et al., 1992). It is classified among a subgroup of cardioviruses 
(Pevear et al., 1987) and is a natural pathogen for mice (Roos et al., 1992). In the wild the 
virus causes an infection of the enteric tract and may occasionally become paralytic (Dal 
Canto et al., 1995). TMEV is one of the first viruses able to produce chronic infection, 
which is important for studying demyelination (Dal Canto et al., 1980). It is divided into 
two subgroups, GDVII and Theiler's original (TO), based on its neurovirulence in mice. 
The GDVII subgroup is highly virulent producing encephalitis and death in less than a 
week in most animals (Dal Canto et al., 1995). The TO subgroup produces a chronic 
persistent CNS infection, which results in inflammatory demyelination (Dal Canto et al., 
1980). However, there is a spectrum of susceptibility to TMEV-induced demyelination 
among mouse strains (Dal Canto et al., 1980).  
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Lysolecithin is a lipid with detergent-like properties. It is thought to cause demyelination 
by acting as a membrane-solubilizing agent with a particular toxicity to myelinating cells 
(Woodruff and Franklin, 1999). Lysolecithin causes CNS demyelination when focally 
injected in vivo into specific myelinated fiber tracts (Birgbauer et al., 2004). Demyelination 
is observed within 30 minutes of lysolecithin injection; however, there is an accumulation 
of dense bodies and degenerating mitochondria (Hall, 1972). Lysolecithin allows for the 
study of remyelination since remyelination is observed within 14 days following injection 
(Hall, 1972). While this model provides consistent demyelination and remyelination, 
specificity of target remains unclear.  
 
Exposure of the neurotoxicant, cuprizone (bis-cyclohexanone-oxaldihydrazone), to young 
adult C57BL/6 mice induces a synchronous and consistent model for demyelination 
followed by remyelination (Mason et al., 2001; Matsushima and Morell, 2001; Skripuletz 
et al., 2008). Demyelination occurs at sites large enough to allow detectable cellular, 
molecular, biochemical and morphological changes (Matsushima and Morell, 2001). 
Removal of cuprizone from the diet allows for the study of remyelination (Matsushima and 
Morell, 2001). Previous work (Skripuletz et al., 2008) has shown that cortical 
demyelination and remyelination is prominent in the cuprizone model. Although cuprizone 
is a toxin, titrating it down to 0.2% allows for demyelination with minimal toxic effects 
(Matsushima and Morell, 2001).  
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Although the exact mechanism of the cuprizone model of demyelination is unknown, 
cuprizone is known to be a copper chelator. The feeding of cuprizone is thought to induce 
a copper deficiency (Suzuki and Kikkawa, 1969; Kesterson and Carlton, 1971; Pattison 
and Jebbett, 1971; Blakemore, 1972; Blakemore, 1973; Ludwin, 1978),  which is thought 
to be detrimental to mitochondrial function  (Venturini, 1973) and that it is a disturbance of 
energy metabolism in the oligodendrocytes and cell function that leads to demyelination 
(Cammer and Zhang, 1993; Fujita et al, 1993; Komoly et al., 1987; Morell et al., 1998). 
This demyelination can be detected early without damaging cell types other than 
oligodendrocytes (Blakemore, 1973; Cammer and Zhang, 1993; Fujita et al., 1990; 
Komoly et al., 1987; Ludwin, 1978).  The hypothesis as to why oligodendrocytes are 
preferentially susceptible to the copper deficit is that these cells must maintain a great 
amount of myelin and this great metabolic demand places it at risk if the demand is not met 
(Matsushima and Morell, 2001).  
 
While axonal pathology contributes to much of the dysfunction associated with MS (Dutta 
and Trapp, 2011), the early pathologic events responsible for axonal deterioration remain 
unclear. In this study we have chosen to exploit the cuprizone toxicity model to address 
whether the maintenance of the AIS integrity is dependent on the presence of an intact 
myelin sheath because this model not only provides limited off target toxicity, is easy to 
administer but also provides a consistent course of demyelination followed by 
remyelination of the 5th layer of the cerebral cortex (Skripuletz et al., 2008). Together, 
these features make cuprizone the ideal model to test our hypothesis that the maintenance 
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of the AIS of myelinated axons requires myelin-axon interactions and that re-establishment 
of these interactions initiates the restoration of AIS integrity.  
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Materials and Methods 
  
 
 
Animals 
 Five week old male C57/black6 mice were purchased from the Jackson Laboratory 
(Bar Harbor, ME) and maintained in the Virginia Commonwealth University Division of 
Animal Resources vivarium, which is an AAALAC accredited facility. Treatment was 
initiated after allowing the mice to acclimate for one week.   Food and water were provided 
ad liberatum. All procedures were conducted in accordance to the methods outlined in the 
approved IACUC protocol AD20186. 
 Ground rodent chow (5001 Rodent Diet; PMI Nutrition International, LLC, 
Brentwood, MO) was mixed with cuprizone (Bis-cyclohexanone oxaldihydrazone; Sigma-
Aldrich, St. Louis, MO) and vigorously shaken for 5 minutes following a previously 
described protocol (Hiremath et al., 1998; Dupree et al., 2004).  Treated animals were 
removed from cuprizone after either 3 or 5 weeks of treatment and were immediately 
processed for tissue analysis. An additional group was maintained on cuprizone for 5 
weeks followed by an additional 3 weeks on normal (non-cuprizone) chow. Three weeks 
of normal chow has been previously shown to maximize myelin repair. (See Table I for 
treatment dose and duration and for the number of mice analyzed in each treatment group). 
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 3 weeks 5 weeks 5+3 weeks 
0% Cuprizone 3 3 3 
0.2% Cuprizone 3 4 4 
Table I. Cuprizone dose and duration.  A minimum of 3 mice 
were maintained on a ground chow diet either without (0% 
cuprizone) or with (0.2% cuprizone) for 3 or 5 weeks. These 
durations were chosen based on previous studies that have 
reported that the initial signs of demyelination occur following 3.5 
weeks of exposure and maximum demyelination occurs after 5 
weeks of exposure. An additional group of mice were maintained 
for an addition 3 weeks on non-cuprizone containing ground chow 
to facilitate remyelination.   
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Tissue Preparation  
 
Anesthesia  
After the appropriate treatment times, mice were deeply anesthetized using 0.016 mL/gm 
body weight of a 2.5% solution of avertin (2, 2, 2 tribromoethanol) (Sigma-Aldrich; St. 
Louis, MO) in 0.9% sodium chloride (NaCl) (Sigma-Aldrich). The working dilution of 
2.5% avertin was generated from a stock solution of 100% avertin which was dissolved in 
tert-amyl alcohol (Acros Organics, NJ) and stored at 4°C. The appropriate volume of 
avertin was injected intraperitoneally using a 27 gauge, ½ inch long needle attached to a 1 
milliliter syringe (Becton, Dickinson & Company, Franklin Lakes, NJ). Following 
injection the mouse was returned to its cage to allow for the anesthesia to take effect. 
Consciousness was checked using a combination of a toe pinch and corneal reflex.  
 
Perfusion 
After anesthesia the mouse was stabilized ventral side up on a dissecting block. An initial 
incision was made from the abdomen to the sternum and two more incisions were made 
from the sternum to each axilla resulting in a ‘Y’ shaped incision. To expose the heart the 
diaphragm was severed and the rib cage was excised. A cut was made in the right atrium to 
allow for an exit point for the blood and perfusate. A 22 gauge 1 inch needle was then 
inserted into the left ventricle making sure not to puncture the interventricular septum or 
the aorta.  
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Following a 0.9% NaCl flush for 5-7 minutes or until the perfusate flowed clear, the mouse 
was transcardially perfused with freshly prepared phosphate buffer containing 4% 
paraformaldehyde (Electron Microscopy Services, Hatfield, PA). After muscle twitching 
stopped, the fixative solution was continued for 10 minutes, at a rate of 7 milliliters per 
minute, to allow for a mild fixation, which is beneficial for immunocytochemical labeling. 
The entire brain, with the exception of the olfactory bulbs, was immediately harvested and 
placed in phosphate buffered saline (PBS) (137 mM NaCl, 10 mM Na2HPO4, 1.8 mM 
KH2PO4, 2.7 KCl, with a pH of 7.4) containing 30% sucrose. Following 48 hours of 
incubation in the PBS-containing sucrose, the brains were frozen in Optimal Cutting 
Temperature (OCT), sectioned at 10 µm using a Leica CM 1850 cryostat. Previous work 
(Skripuletz et al., 2008) observed consistent cortical demyelination in regions spanning 
between bregma -0.94 and bregma -1.8. Based on this previous work, 15 sets of six 10 µm 
sections harvested from cortical regions, approximately 90 um apart, were collected. Slides 
were labeled with cuprizone treatment and mouse number. Each set of 6 sections were 
placed on ProbeOn Plus slides (Fisher) and stored at -80°C until they were immunolabeled.  
 
Immunocytochemistry 
Slides were randomly selected and removed from the -80°C freezer and allowed to dry 
before cutting away excess OCT from the perimeter. Using a PAP pen (Super PAP Pen, 
Electron Microscopy Sciences), a hydrophobic barrier was drawn around the tissue to 
maintain solutions on the slide. Slides were then placed in -20°C acetone and allowed to 
permeabilize for 10 minutes. The slides then underwent three 5 minute rinses in PBS 
   
 27 
followed by a 15 minute incubation in blocking solution. The blocking solution contained 
~5% cold water fish gelatin and 0.1% Triton X-100 in PBS.  The exception to this general 
protocol was with labeling for the myelin protein myelin basic protein (MBP). MBP is a 
cytoplasm protein that is more difficult to immune-label and additional permeabilization is 
required. Therefore, when using the MBP antibody, 1% Triton X-100 was used in place of 
the 0.1% Triton X-100 concentration stated above. After slides were removed from the 
blocking solution, they were incubated in the appropriate primary antibody at the 
concentration shown in Table II. 
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Primary 
Antibody 
AnkyrinG 
(ankG) 
(NeuroMab) 
Dephosphorylated 
Neurofilament 
(SMI 32) 
(Covance) 
Myelin Basic 
Protein 
(MBP) 
(Sternberger 
Monoclonal) 
Caspr 
(gift from Dr. 
Manzoor 
Bhat) 
Amyloid 
Precursor 
Protein (APP) 
(Invitrogen) 
Neuronal 
Nuclei 
(NeuN) 
(Millipore) 
Dilution 1:200 1:1000 1:1000 1:1000 1:500 1:1000 
Secondary 
Antibody 
(1:500) 
Alexa 594 
Anti-Mouse 
IgG2a 
Alexa  594 
Anti-Mouse 
IgG1 
Alexa 488 
Anti-Mouse 
IgG2b 
Alexa 488 
Anti-
Guinea Pig 
IgG 
Alexa 488 
Anti-rabbit  
IgG 
Alexa 594 
Anti-Mouse 
IgG1 
Table II. Primary and Secondary Antibody Concentrations   
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The tissue was incubated overnight at 4°C in the primary antibody in a humidified 
chamber to prevent drying. The next day three PBS rinses and the 15 minute blocking 
steps were repeated. The slides were then incubated for 90 minutes in secondary antibody 
(Table II), which were fluorescently conjugated and diluted to a 1:500 concentration in the 
blocking solution, in a light tight, humidified chamber at room temperature. After removal 
of the secondary antibody, the slides were dipped once in PBS to remove the secondary 
antibody followed by three additional 5 minute rinses. They were then incubated in the 
nuclear label bisBenzamide at a concentration of 1:1000 for 5 minutes. The slides were 
then exposed to three 5 minute rinses in PBS and then mounted with Vectashield™ 
(Vector Laboratories) medium, cover slipped and imaged. 
 
Image Collection 
 
Confocal Microscopy 
All sections were imaged using a Zeiss LSM 700 confocal laser scanning microscope (Carl 
Zeiss Microscopy, LLC, Thornwood, NY), which is housed in the VCU Department of 
Anatomy and Neurobiology Microscopy Facility. Sixteen fields were collected per mouse. 
All images were collected from cortical layer V, since this region is not only clearly 
identifiable with a bisBenzamide stain (Figure 2), but also contains a relative homogenous 
neuronal population with approximately 80% cortical Pyramidal neurons and 20% 
interneurons. Right or left hemisphere was randomly chosen and two fields from both 
medial and lateral aspects were sampled. The longitudinal fissure was used to identify the 
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midline of the brain. Adjacent to the longitudinal fissure, AIS are oriented in an oblique 
direction and the delineation of the cortical layers is less clearly demarcated. In order to 
ensure comparison of comparable cortical regions, 2 medial images were collected just 
lateral to the region of the obliquely oriented AIS.   
 
At the lateral extent of the cortical regions, the cortical layers bend to accommodate the 
curvature of the ventral aspect of the brain. Similar to the cortical regions adjacent to the 
longitudinal fissure, the AIS in these most lateral extents are also obliquely oriented. 
Therefore, the two lateral images were collected from the regions where the AIS were 
obliquely oriented. In these regions cortical layer 5 was easily and reproducibly identified. 
In all cases a z-stack of 14 optical planes was collected using Nyquist sampling, which was 
calculated at a step size of 0.51 μm. Gain and offset were held between 680-710, using 
fluorescent beads as a standard and adjusting gain and offset settings to the same intensity. 
Table III contains a list of settings used for image collection. All image analyses were 
conducted under the supervision of Dr. Scott Henderson, Director of the VCU Microscopy 
Facility. 
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Figure 2. bisBenzamide labeling demarcating cortical layers. Cortical layer V, a 
region populated by approximately 80% pyramidal neurons, demyelinates following 
cuprizone treatment. Thus, providing an ideal model for initial segment analysis. 
(bisBenzamide-blue)   
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Gain Offset Pinhole Zoom Objective Format Line Average 
Pixel 
Size 
Step 
Size 
680-710 0 1 Airy Unit 1 40x 
1396 x 
1396 2 0.11 μm  0.51 μm 
Table III. Confocal Microscope Settings 
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Analysis 
Using the image analysis software Volocity™ (Perkin-Elmer, Waltham, MA), which is 
housed in the VCU Department of Anatomy and Neurobiology Image Analysis Facility, 
the number, surface area and length of initial segments were determined.. Optimal data 
collection parameters were determined based on the recommendations of Dr. Scott 
Henderson. For every z-stack analyzed the minimal threshold was determined by checking 
maximum intensity of objects that were certain to not be initial segments and identifying 
the minimum pixel intensity of objects that were identified as AIS. Although these 
minimum intensities varied from image to image, the variability was slight ranging 
between 210 and 400. Because AIS are more elliptical, shape was used to exclude nodes of 
Ranvier and lipofuscin, which is a build-up of strongly oxidized proteins and lipids known 
to accumulate in stressed or aged cells (Jung et al., 2007). More spherical objects were 
excluded by only collecting objects that had a minimum shape factor of 0.4.  To further 
ensure that nodes of Ranvier were not mistakenly analyzed, collected objects less than 15 
μm3, which is consistent with the area of a node but dramatically smaller than AIS, were 
excluded.  ImageJ (NIH) was also used to analyze length and number of initial segments. 
All AIS counts, indicating the numbers of AIS analyzed were presented as actual values 
(mean +/- SEM). AIS surface area and length data collected using Volocity™ are 
presented as percent of the mean +/- percent of SEM while length values collected using 
ImageJ are presented as actual value means +/- SEM. All data were statistically analyzed 
using a t-test comparing untreated to 3 weeks treated, untreated to 5 weeks treated or 
untreated against 5 weeks treated followed by 3 weeks of myelin repair.  
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Results 
 
 
Cortical layer V demyelinates following cuprizone treatment 
In order to initiate cortical demyelination followed by remyelination, cuprizone was 
administered at a 0.2% concentration consistent with the treatment paradigm used by 
Skripuletz et al. (2008). Immunolabeling for myelin basic protein (MBP) provided a 
qualitative assessment of the extent of myelin loss in the cortical layer V of mice 
maintained on ground chow containing 0.2% cuprizone. As shown in Figure 3A, robust 
MBP labeling was observed in mice maintained on ground chow without cuprizone. In 
contrast, as early as 3 weeks of cuprizone treatment, a reduction in the level of MBP 
labeling was consistently observed in cortical layer V (Figure 3B). Interestingly, cortical 
demyelination was not observed by Skripuletz et al. (2008) following only 3 weeks of 
cuprizone exposure. Following 5 weeks of treatment, an exposure duration that has 
previously been reported to elicit maximum CNS demyelination (Matsushima and Morell, 
2001), MBP labeling revealed a continued, progression of myelin loss throughout all 
cortical layers (Figure 3C). Importantly, maintaining the mice for an additional 3 weeks on 
ground chow without cuprizone resulted in an increase in MBP labeling, which is 
consistent with remyelination of cortical layer V (Figure 3D). Together, this qualitative 
assessment confirmed the temporal course of demyelination/remyelination induced by  
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Figure 3. Cortical layer V demyelinates following cuprizone treatment. Immunolabeling of 
myelin basic protein (green), a prominent protein of the myelin sheath, was used to assess control 
levels of myelin (A, no cuprizone treatment), and the extent of demyelination (B, 3 week treated; C, 
5 week treated) and remyelination (D, 5 weeks treated, 3 weeks recovery). The yellow dashed line 
indicates the approximate level of cortical layer V. Scale bar: 40 µm 
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cuprizone exposure and cuprizone withdrawal. Moreover, it illustrates that the mice used 
for our analyses of the AIS also exhibited a similar profile of myelin damage and repair.    
 
Cell death was not observed among treatments 
As the above qualitative assessment revealed that the cuprizone toxicity model was 
successful in inducing demyelination and remyelination in the cerebral cortex, we wanted 
to determine whether this loss of myelin resulted from neuronal death. Previous work from 
our laboratory (Dupree et al., 2004) and others (Matsushima and Morell, 2001) has shown 
that cuprizone demyelination results from oligodendrocyte death; however, demyelination 
might also be a consequence of neuronal death. Since the basis of my study was to assess 
AIS changes induced by demyelination as the primary insult, assessment of neuronal and 
axonal health is critical. The first approach in assessing neuronal health was to determine 
whether cuprizone treatment resulted in neuronal loss in cortical layer V. To assess the 
neuronal population of cortical layer V, sections were immunolabeled with an antibody 
directed against NeuN, a neuronal specific marker (Kim et al., 2009). No differences were 
observed between any of the cuprizone treatment groups and the non-treated group with 
regard to the number of NeuN positive cells per microscopic field (76.5±4.8, 69.75±5.8, 
71±4.1, and 78.5±6.8 NeuN positive cells per microscopic field for untreated, 3 week 
treated, 5 week treated and 5+3 weeks treated respectively) (Figure4). Importantly, these 
findings strongly indicate that cuprizone treatment did not induce neuronal cell death in the 
cortical layer V consistent with the idea that the observed demyelination observed with the  
   
 37 
 
Figure 4.  Cell death was not observed among treatments. NeuN, a neuronal cell marker, was used 
to quantify neuronal number in layer V of the cortex before (A, no cuprizone treatment), during (B, 3 
week treated; C, 5 week treated) and after (D, 5 week treated, 3 weeks recovery. Scale bar: 15 µm 
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MBP labeling was not a consequence of neuronal death with subsequent axon 
degeneration.  
 
The extent of axonal pathology did not differ among treatments 
Our findings with NeuN strongly indicate that neuronal cell death was not prevalent in the 
cuprizone treated mice; however, more subtle neuronal pathologies could potentially be 
caused by the toxic effect of cuprizone, which might compromise AIS integrity 
independent of myelin loss. To further explore this possibility, we used immunolabeling to 
assess pathologies associated with the neuronal cytoskeleton and axonal transport. 
Previous studies have used the SMI-32 antibody, an antibody that recognizes non-
phosphorylated neurofilaments, as an indicator of axonal cytoskeletal pathology (Trapp et 
al., 1998). In the mature axon, neurofilaments are extensively phosphorylated and the loss 
of this phosphorylation is indicative of compromised cytoskeletal integrity. As shown in 
Figure 5, minimal reactivity against SMI-32 was observed in all of the mice and no 
difference between the treated (Figure 5B-D) and untreated (Figure 5A) groups was 
observed. These findings demonstrate that the state of neurofilament phosphorylation was 
not altered with cuprizone exposure. 
  
Although the findings from the SMI-32 labeling indicated that the cytoskeleton was not 
compromised, neuronal health was further assessed by labeling the cortical layer V with an 
antibody directed against amyloid precursor protein (APP). APP is a protein that is 
normally expressed by CNS neurons and is transported along the axon (Koo et al., 1990).  
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Figure 5. The extent of axonal pathology did not differ among treatments.  Markers of axonal 
pathology, amyloid precursor protein (APP, green) and SMI 32 (anti-dephosphorylated neurofilaments, 
red), revealed no pathology in cortical layer V neurons among any of the treatment paradigms (A, no 
cuprizone treatment; B, 3 week treated; C, 5 week treated; D, 5 weeks treated, 3 weeks recovery). 
Consistent with previous studies axonal pathology as indicated by APP labeling was observed in the 
corpus callosum (inset). Scale bar: 10 µm 
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Therefore, the expression of APP is not pathological; however, accumulations of this 
protein within the axon are indicative of compromised axonal transport and subsequently, 
compromised axonal health.  As shown in Figure 5, APP positive accumulations were not 
observed in the cortical layer V consistent with unimpaired axonal transport. Although 
APP accumulations were not observed in the cortical layer V, APP accumulations were 
observed in the corpus callosum of the mice treated with cuprizone for 5 weeks (Figure 5, 
inset). The presence of these accumulations in the corpus callosal axons in cuprizone 
treated mice is consistent with previous studies (Tsiperson et al., 2010; Skripuletz et al., 
2013) further confirming the validity of our cuprizone treatment and that the lack of APP 
labeling in the cortex was not due to technical error. Importantly, a qualitative assessment 
of APP accumulations indicated that these pathologic markers were dramatically less 
prevalent in the corpus callosum of mice that were treated with cuprizone for 5 weeks 
followed by an additional 3 weeks of recovery. The reduction in the frequency of APP 
accumulations is consistent with axonal recovery subsequent to toxin withdrawal.  
Together, these findings suggest that neuronal toxic effects from cuprizone treatment were 
minimal.   
 
Caspr clustering reveals nodes of Ranvier and distal end of AIS 
To quantify the integrity of the AIS in mice following demyelination, cortical sections 
were immunolabeled with an antibody directed against AnkG, an AIS marker (Buffington 
and Rasband, 2011). Although the AnkG antibody provided robust labeling of the AIS, 
small structures not consistent with AIS in longitudinal orientation were also observed. In 
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coronal sections, the AIS of cortical layer V should be cut in longitudinal orientation; 
however, to determine whether these small, ankG-labeled structures were AIS cut in cross 
section, cortical sections were double labeled with antibodies directed against AnkG and 
caspr, a paranodal marker (Bhat et al., 2001)). Caspr was chosen since ankG also clusters 
in nodes of Ranvier (Buffington and Rasband, 2011). If the small, ankG labeled structures 
were nodes of Ranvier, then the caspr labeling would bracket the ankG labeling consistent 
with the paranode-node-paranode structure. As shown in Figure 6, qualitative analysis of 
the caspr/AnkG double-labeled sections confirmed the presence of nodal clusters as caspr 
labeling appeared as two adjacent accumulations separated by a small ankG labeled region, 
corresponding to the node of Ranvier (Figure 6A). Consistent with demyelination, both 
ankG nodal labeling and caspr paranodal labeling were reduced following 5 weeks of 
cuprizone treatment (Figure 6B).  
 
AIS Analysis 
As the above analysis revealed, the cuprizone model was successful in eliciting 
demyelination with minimal toxic effects on the axon. To analyze AIS integrity following 
demyelination, an antibody directed against ankG was used to identify the AIS of the 
cortical neurons of layer V. Using the image analysis software, Volocity™ (Perkin-Elmer, 
Waltham, MA), number, length and area of AIS were determined. These values were 
compared against their untreated groups as percentages of controls (untreated). All values 
are shown in Tables IV and VI. ImageJ was also used to quantify number and length of 
AIS as shown in Tables V and VII.  The number of AIS in the medial region of the cortex,  
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Figure 6. Nodes of Ranvier decrease following cuprizone treatment. Caspr (green), a known 
paranodal marker, was used to qualitatively assess the control levels of nodes, labeled with an antibody 
against the known AIS and node protein, ankyrinG (red; A, 5 week untreated) and the breakdown of 
nodes following cuprizone treatment (B, 5 week treated). Scale bar: 10 µm 
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as compared using Volocity™ , appeared to be consistently reduced; however, statistical 
analysis determined that these apparent reductions were no significantly different (p=0.44, 
0.30 and 0.39 for 3, 5 an 5+3 weeks, respectively) (Tables IV and V). In support of this 
conclusion, ImageJ analysis of the number of AIS confirmed no difference between treated 
and untreated mice for any of the treatment groups.  Similarly, the number of AIS, as 
analyzed by Volocity™, observed in the lateral region of cortical layer V showed no 
difference between  treated and untreated groups(p= 0.78, 0.81 and 0.07 for 3, 5 an 5+3 
weeks, respectively). Consistent with analysis of the medial cortex, the analysis of the 
lateral cortical region with ImageJ confirmed that neither the number nor the length of the 
AIS was significantly different between untreated and treated groups for the lateral regions 
of cortical layer V (Tables VI and VII). Previous work (Mason et al., 2001) has shown that 
axonal caliber changes with demyelination and remyelination; therefore, we measured the 
surface area of AIS as an indicator of axon caliber. Our data indicated no significant 
change in the average surface area of the AIS from either the medial or lateral regions of 
cortical layer V between mice maintained on normal and cuprizone containing chow.  
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Figure 7. AnkG labeling of axon initial segments revealed no significant 
difference  in number, length or surface area following demyelination in the 
medial region of cortex. Cortical sections immunolabeled with ankG revealed 
robust labeling of medial cortical layer V neurons in both cuprizone treated (B, 3 
week; D, 5 week; F, 5 week, 3 weeks recovery) and untreated (A, 3 week; C, 5 week; 
E, 5 week) mice. Volocity™ and ImageJ analysis revealed no significant difference 
in number, length or surface area. Scale bar: 15 µm 
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Quantitative analysis of medial cortex using  Volocity™ 
 
3 week 5 week 5+3 week 
No cup Cup No cup Cup No Cup Cup 
Number 
 
100±19.3 
 
 
77.5±23.8 
 
 
100±35.7 
 
 
50.5±40.6 
 
 
100±22.9 
 
 
66.7±40.3 
 
Length 
(µm) 
 
100±14.7 
 
 
67.3±9.8 
 
 
100±26.8 
 
 
98.2±47.8 
 
 
100±37.0 
 
 
119.7±32.4 
 
Surface 
Area 
(µm2) 
100±9.0 84.3±9.9 100±17.0 90.6±27.7 100±13.6 
 
107.8±28.7 
 
Table IV. Number, length (µm) and surface area (µm2) of medially located AIS reported 
from Volocity™ calculated as percentages ± SEM  
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Figure 8. Number of axon initial segments was not significantly 
changed following demyelination in medial cortex. Although the 
average number of initial segments in layer V for all treatment groups 
appeared reduced as compared to mice maintained on normal chow, the 
differences were not significant. Data are presented as mean percent of 
control ± SEM. 
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Figure 9. Length of axonal initial segments was not altered 
following demyelination in medial cortex.  Data are presented as 
mean percent of control ± SEM. 
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Figure 10. Surface area of axon initial segments was not changed 
following demyelination in medial cortex.  Data are presented as 
mean percent of control ± SEM. 
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Quantitative analysis of medial cortex using ImageJ 
 
3 week 5 week 5+3 week 
No cup Cup No cup Cup No Cup Cup 
AIS 
Number 
220.7±35.0 193.0±34.6 195.3±37.0 191.7±22.1 216.3±32.7 188.0±27.3 
AIS 
Length 
17.6±1.0 17.1±1.5 15.4±0.7 15.9±0.6 14.1±0.8 14.5±0.1 
Table V. Number and length of medially located AIS. Using Image J, neither the 
number nor the average length of cortical layer V AIS was significantly different between 
cuprizone treated and untreated mice. Data presented as  mean  ±  SEM 
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Figure 11. AnkG labeling of axon initial segments revealed no significant 
change in number, length or surface area following demyelination in lateral 
cortex. Cortical sections immunolabeled with ankG revealed robust labeling of 
lateral cortical layer V neurons in both cuprizone treated (B, 3 week; D, 5 week; F, 5 
week, 3 weeks recovery) and untreated (A, 3 week; C, 5 week; E, 5 week) mice. 
Volocity™ and ImageJ analysis revealed no significant difference in number, length 
or surface area. Scale bar: 15 µm 
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Quantitative analysis of lateral cortex using Volocity™ 
 
3 week 5 week 5+3 week 
No cup Cup No cup Cup No Cup Cup 
Number 
 
100±14.4 
 
 
 
106.2±19.5 
 
 
 
100±15.9 
 
 
 
92.7±3.2 
 
 
 
100±7.6 
 
 
 
113.8±6.7 
 
 
Length 
(µm) 
 
100±28.5 
 
 
 
91.2±23. 6 
 
 
 
100±23.5 
 
 
 
128.5±34.6 
 
 
 
100±12.3 
 
 
 
113.5±17.4 
 
 
Surface 
Area 
(µm2) 
100±4.0 
 
44.8±36.4 
 
100±39.9 
 
60.8±21.7 
 
100±17.6 
 
 
79.9±12.8 
 
 
Table VI. Number, length (µm) and surface area (µm2) of laterally located AIS reported 
from Volocity™ calculated as percentages of control ± SEM 
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Figure 12. Number of axonal initial segments was not significantly 
changed following demyelination in lateral cortex.  Data are presented 
as mean percent of control ± SEM.  
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Figure 13. Length of axon initial segments was not changed following 
demyelination in lateral cortex.  Data are presented as mean percent of 
control ± SEM. 
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Figure 14. Surface area of axon initial segments was not changed 
following demyelination in lateral cortex.  Data are presented as 
mean percent of control ± SEM.  
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Quantitative analysis of lateral cortex using ImageJ 
 
3 week 5 week 5+3 week 
No cup Cup No cup Cup No Cup Cup 
AIS 
Number 
248.0±42.4 216.3±31.4 199.0±38.1 233.3±12.5 206.7±4.1 185.3±33.6 
AIS 
Length 
18.9±1.1 19.2±0.1 19.0±0.2 19.1±1.2 17.2±0.6 18.0±0.7 
Table VII. Counts and length of laterally located AIS ImageJ reported as mean  ±  SEM 
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Discussion 
 
 
 
The goal of this study was to determine if maintenance of the myelin sheath is required for 
the preservation of AIS in CNS myelinated axons. While it is known that axon pathology 
is a major contributor to impaired motor, sensory and cognitive dysfunction associated 
with multiple sclerosis (Dutta and Trapp, 2011), the early events responsible for axonal 
pathology remain unclear. It is recognized that maintaining proper axonal function is 
intimately related to proper establishment and maintenance of axonal domains such as the 
node of Ranvier and the AIS (Bhat et al, 2001; Buttermore et al., 2013). Moreover, 
previous studies from our laboratory (Dupree et al., 1999; Dupree et al., 2004; Marcus et 
al., 2006; Pomicter et al., 2010) and others (Dugandžija-Novaković et al. 1995; Salzer et 
al., 1997; Rasband et al., 1998; Rasband et al., 1999; Tait et al., 2000; Bhat et al., 2001) 
have demonstrated that myelin contact is required for both the formation and maintenance 
of the node of Ranvier. However, formation of the AIS of myelinated axons does not 
require myelin axon contact (Zonta et al., 2011). Therefore, the node of Ranvier and the 
AIS, two axonal domains that cluster many of the same proteins (Buffington and Rasband, 
2011), utilize different mechanisms for molecular formation. Presently, no study has 
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addressed whether myelin is required for maintaining the AIS. Here, we provide the first 
evidence that the myelin sheath is not essential for maintaining the integrity of the AIS.   
 
To assess changes in AIS integrity, we analyzed AIS number, length and surface area of 
cortical neurons following demyelination. Previous studies have shown that the AIS is the 
site of action potential (AP) initiation (Stuart and Sakmann, 1994; Mainen et al., 1995). 
Therefore, any structural changes at the AIS would have an impact on the excitability of 
neurons and the circuits in which they function (Baalman et al., 2013). Key players in AIS 
function and AP initiation are the voltage gated sodium channels. In the AIS two forms 
predominate: the immature isoform known as Nav1.2, which is clustered in the proximal 
end of the AIS and the mature isoform known as Nav1.6, which is clustered in the distal 
end of the AIS (Buffington and Rasband, 2011). In addition to the sodium channels, other 
ion channels also participate in regulating AIS activity, although the precise interplay 
among these channels remains poorly understood (Popovic et al., 2011). However, it is 
recognized by most studies that physical properties of the AIS, including length and 
location (Colbert & Johnston, 1996; Khaliq & Raman, 2006; Palmer & Stuart, 2006; Kole 
et al. 2007; Shu et al. 2007), are critical to AIS function. Therefore, we elected to use a 
marker of the AIS that reveals the distribution of all classes of voltage gated sodium 
channels and to use this marker to quantify physical properties of the AIS.  
 
In order to quantify the effects of myelin loss on AIS integrity, we utilized a well-
established murine model of CNS demyelination/remyelination that induces minimal off 
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target toxic effects (Matsushima and Morell, 2001). Consistent with the requirements for 
this study, Skripuletz et al. (2008) reported that administration of 0.2% cuprizone initiated 
consistent cortical layer V demyelination while removal of cuprizone allowed for myelin 
replacement. Based on the Skripuletz et al. report (2008), C57/black6 mice were 
maintained on ground chow containing 0.2% cuprizone for 3 weeks, 5 weeks and 5 weeks 
followed by 3 weeks on non-cuprizone containing chow, which allowed for remyelination. 
Immunocytochemical labeling of an AIS cytoskeletal scaffolding protein, ankG 
(Buffington and Rasband, 2011), showed no significant difference in the number of AIS 
from either the medial or lateral regions of cortical layer V regardless of the treatment. 
Similarly, there was no difference in length or surface area of medially or laterally located 
initial segments among the treatments. We had proposed that the maintenance of the AIS 
of myelinated axons requires myelin-axon interactions and that re-establishment of these 
interactions would trigger the restoration of AIS integrity. However, our data suggest that 
maintenance of the AIS is not dependent on myelin contact. Importantly, these findings 
demonstrate that clusters of the same proteins along the same axon employs distinct 
mechanisms for maintaining the integrity of their specific domains.    
 
Although neither the number nor structure of AIS was changed in the present study, other 
injury paradigms have resulted in significant changes in CNS AIS. Using a 
photothrombotic stroke model, Hinman et al. (2012) reported a significant shortening of 
AIS in the peri-infarct cortical regions.  Moreover, the region of the AIS that exhibited the 
greatest structural change was the distal end, which has been proposed as the action 
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potential spike trigger zone (Popovic et al., 2011). Therefore, structural and molecular 
changes to this region may have profound effects on AIS and, ultimately, axonal function. 
Hinman et al. (2012) did not investigate potential mechanisms responsible for the AIS 
structural changes; however, they hypothesized that calpain mediated cleavage may be 
involved, which is consistent with a previous report by Schafer et al (2009).  
 
In the earlier work of Schafer et al. (2009), the middle cerebral artery occlusion stroke 
model was employed. The ischemic injury resulted in rapid and complete disruption of 
AIS protein clustering including the loss of ion channels, ankG and βIV spectrin 
independent of neuronal cell death or axonal degeneration. Although AIS domains were 
severely altered, nodes of Ranvier remained intact. These authors proposed that elevated 
levels of intracellular calcium activated the calcium dependent cysteine proteinase calpain, 
which in turn cleaved ankG and βIV spectrin. Although these authors did not demonstrate 
an increase in intracellular calcium, calpain inhibition preserved AIS molecular 
organization.  
 
Interestingly, in multiple sclerosis, Waxman and colleagues proposed that increased levels 
of calcium may result from reversing the Na+/Ca+ exchanger (Craner et al., 2004).  In 
support of this proposal, these authors reported that along demyelinated axons in multiple 
sclerosis, Nav1.6 and Nav 1.2 channels are diffusely distributed. Moreover, they reported 
that these abnormally distributed Nav1.6 channels produce a persistent Na+ current that 
drives the Na+/Ca+ exchanger to import a damaging level of calcium inside the 
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demyelinated axons (Waxman, 2006). With this in mind, combined with the findings of 
Rasband and colleagues (Schafer et al., 2009), it is plausible to predict that demyelination, 
distal to the AIS, would result in altered Na ion channel function subsequently inducing an 
increase in axonal calcium levels and calpain mediated-cleavage of the axonal cytoskeleton 
and cytoskeletal scaffolding proteins.  Based on the findings from the current study, this 
pathologic cascade is not initiated in the AIS merely by demyelination.  
 
Although the administration of cuprizone recapitulates the demyelination aspect of MS, 
cuprizone does not mimic the T cell mediated inflammatory response of the disease 
(McMahon et al., 2001). Therefore,  altered Na+ channel distribution, which accompanies 
demyelination in MS as reported by Waxman et al. (2004), may require an additional 
pathologic event such as T cell mediated inflammation that is present in MS (Dittel, 2008) 
but absent in the cuprizone model (McMahon et al., 2001). Presently, this possibility is 
being tested in our lab and preliminary findings indicate altered AIS structure of the 
cortical layer V neurons in mice induced with EAE, a CNS inflammation model that is 
frequently used to study certain aspects of MS (Steinman and Zamvil, 2006).  
 
In conclusion, although the node of Ranvier and AIS cluster the same proteins, we show 
that they have distinct mechanisms for maintenance. While myelin is necessary to establish 
and maintain the integrity of the node, the AIS is formed and maintained independent of 
myelin.  
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